{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:42:17Z","timestamp":1789663337118,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017539","name":"Theodor Bilharz Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017539","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Non-coding RNA Research"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ncrna.2022.12.006","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T19:48:44Z","timestamp":1672429724000},"page":"155-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Circulating liver cancer stem cells and their stemness-associated MicroRNAs as diagnostic and prognostic biomarkers for viral hepatitis-induced liver cirrhosis and hepatocellular carcinoma"],"prefix":"10.1016","volume":"8","author":[{"given":"Marwa","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami Mohamed","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha Abdelaal","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"El-Ahwany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Zoheiry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elzallat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncrna.2022.12.006_bib1","first-page":"1","article-title":"Evaluation of HCV-related liver fibrosis post-successful DAA therapy, Egypt","volume":"11","author":"Ehsan","year":"2021","journal-title":"Liver J"},{"key":"10.1016\/j.ncrna.2022.12.006_bib2","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.5114\/aoms.2019.86621","article-title":"MicroRNA-122a as a non-invasive biomarker for HCV genotype 4-related hepatocellular carcinoma in Egyptian patients","volume":"15","author":"El-Ahwany","year":"2019","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.ncrna.2022.12.006_bib3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41590-018-0044-z","article-title":"The immunology of hepatocellular carcinoma","volume":"193","author":"Ringelhan","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ncrna.2022.12.006_bib4","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.26452\/ijrps.v10i4.1574","article-title":"Effect of Interferon-Beta (IFN-\u03b2) on tumor suppressor and apoptotic markers in hepatocellular carcinoma cell line","volume":"10","author":"Okasha","year":"2019","journal-title":"Int. J. Res. Pharm. Sci."},{"key":"10.1016\/j.ncrna.2022.12.006_bib5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ncrna.2022.12.006_bib6","article-title":"Circulating microRNAs as biomarkers in hepatocellular carcinoma screening a validation set from China","volume":"94","author":"Jiang","year":"2015","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.ncrna.2022.12.006_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.691410","article-title":"Emerging regulatory mechanisms involved in liver cancer stem cell properties in hepatocellular carcinoma","volume":"9","author":"Lv","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ncrna.2022.12.006_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev-pathol-012615-044438","article-title":"Cancer stem cells: basic concepts and therapeutic implications","volume":"11","author":"Nassar","year":"2016","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.ncrna.2022.12.006_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.lungcan.2015.11.013","article-title":"Hsa-miR-1246 and hsa-miR-1290 are associated with stemness and invasiveness of non-small cell lung cancer","volume":"91","author":"Kim","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ncrna.2022.12.006_bib10","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3727\/096504017X15051741798389","article-title":"miR-1290 contributes to colorectal cancer cell proliferation by targeting INPP4B","volume":"26","author":"Ma","year":"2018","journal-title":"Oncol. Res."},{"key":"10.1016\/j.ncrna.2022.12.006_bib11","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.biopha.2015.10.005","article-title":"MiR-1290 promotes cancer progression by targeting nuclear factor I\/X(NFIX) in esophageal squamous cell carcinoma (ESCC)","volume":"76","author":"Mao","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ncrna.2022.12.006_bib12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.gene.2016.02.001","article-title":"SMicroRNA-1290 inhibits cells proliferation and migration by targeting FOXA1 in gastric cancer cells","volume":"582","author":"Lin","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.ncrna.2022.12.006_bib13","first-page":"1","article-title":"Tissue miR-200c-3p and circulating miR-1290 as potential prognostic biomarkers for colorectal cancer","volume":"12","author":"Kang","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ncrna.2022.12.006_bib14","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1186\/s12885-021-08729-0","article-title":"Circulating MiR-1290 as a potential diagnostic and disease monitoring biomarker of human gastrointestinal tumors","volume":"21","author":"Xu","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ncrna.2022.12.006_bib15","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3233\/CBM-190007","article-title":"Diagnostic and prognostic value of serum miRNA-1290 in human esophageal squamous cell carcinoma","volume":"25","author":"Sun","year":"2019","journal-title":"Cancer Biomarkers"},{"key":"10.1016\/j.ncrna.2022.12.006_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173144","article-title":"Enhancement of resistance to chemo-radiation by hsa-miR-1290 expression in glioblastoma cells","volume":"880","author":"Khalighfard","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ncrna.2022.12.006_bib17","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317705339","article-title":"A novel serum microRNA-based identification and classification biomarker of human glioma","volume":"39","author":"Xing","year":"2017","journal-title":"Tumor Biol."},{"key":"10.1016\/j.ncrna.2022.12.006_bib18","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1007\/s11255-018-2009-4","article-title":"Five microRNAs in serum as potential biomarkers for prostate cancer risk assessment and therapeutic intervention","volume":"50","author":"Guo","year":"2018","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.ncrna.2022.12.006_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12957-020-01927-3","article-title":"Upregulation of miR-1825 inhibits the progression of glioblastoma by suppressing CDK14 though Wnt\/\u03b2-catenin signaling pathway","volume":"18","author":"Lu","year":"2020","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.ncrna.2022.12.006_bib20","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1166\/jbt.2021.2681","article-title":"miR-1825 accelerates cell proliferation and inhibits cell apoptosis of prostate cancer via targeting suppressor of cancer cell invasion","volume":"11","author":"Bai","year":"2021","journal-title":"J. Biomater. Tissue Eng."},{"key":"10.1016\/j.ncrna.2022.12.006_bib21","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1186\/s12885-016-2863-3","article-title":"Identification of microRNA profile specific to cancer stem-like cells directly isolated from human larynx cancer specimens","volume":"16","author":"Karatas","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ncrna.2022.12.006_bib22","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3390\/cells8080840","article-title":"Role of miRNA-regulated cancer stem cells in the pathogenesis of human malignancies","volume":"8","author":"Khan","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ncrna.2022.12.006_bib23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.ncrna.2022.12.006_bib24","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.gendis.2020.01.014","article-title":"Advances in the early diagnosis of hepatocellular carcinoma","volume":"7","author":"Wang","year":"2020","journal-title":"Genes Dis"},{"key":"10.1016\/j.ncrna.2022.12.006_bib25","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep4.1823","article-title":"Current and emerging tools for hepatocellular carcinoma surveillance","volume":"5","author":"Adeniji","year":"2021","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.ncrna.2022.12.006_bib26","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.3748\/wjg.v22.i13.3547","article-title":"Liver cancer stem cell markers: progression and therapeutic implications","volume":"22","author":"Sun","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ncrna.2022.12.006_bib27","doi-asserted-by":"crossref","first-page":"992","DOI":"10.7150\/ijbs.4454","article-title":"CD133+EpCAM+ phenotype possesses more characteristics of tumor initiating cells in hepatocellular carcinoma Huh7 Cells","volume":"8","author":"Chen","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ncrna.2022.12.006_bib28","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/hep.26168","article-title":"Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma","volume":"57","author":"Yamashita","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.ncrna.2022.12.006_bib29","doi-asserted-by":"crossref","first-page":"12292","DOI":"10.1128\/JVI.05920-11","article-title":"Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts","volume":"85","author":"Ali","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.ncrna.2022.12.006_bib30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.canlet.2017.04.017","article-title":"Hepatitis B virus PreS1 facilitates hepatocellular carcinoma development by promoting appearance and self-renewal of liver cancer stem cells","volume":"400","author":"Liu","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ncrna.2022.12.006_bib31","article-title":"Hepatitis B virus X protein promotes the stem-like properties of OV6+ cancer cells in hepatocellular carcinoma","volume":"8","author":"Wang","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ncrna.2022.12.006_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-018-0492-1","article-title":"Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage","volume":"10","author":"Wang","year":"2018","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.ncrna.2022.12.006_bib33","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.7150\/jca.38048","article-title":"Serum miR-1290 and miR-1246 as potential diagnostic biomarkers of human pancreatic cancer","volume":"11","author":"Wei","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.ncrna.2022.12.006_bib34","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.2147\/OTT.S263934","article-title":"Serum exosomal miR-1290 is a potential biomarker for lung adenocarcinoma","volume":"13","author":"Wu","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ncrna.2022.12.006_bib35","article-title":"Prostate cancer early diagnosis: circulating microRNA pairs potentially beyond single microRNAs upon 1231 serum samples","volume":"22","author":"Liu","year":"2021","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.ncrna.2022.12.006_bib36","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1101\/gr.7179508","article-title":"Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells","volume":"18","author":"Morin","year":"2008","journal-title":"Genome Res."},{"key":"10.1016\/j.ncrna.2022.12.006_bib37","doi-asserted-by":"crossref","first-page":"e982","DOI":"10.1038\/cddis.2013.498","article-title":"The evolutionary young miR-1290 favors mitotic exit and differentiation of human neural progenitors through altering the cell cycle proteins","volume":"5","author":"Yelamanchili","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ncrna.2022.12.006_bib38","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.canlet.2012.10.038","article-title":"Up-regulation of microRNA-1290 impairs cytokinesis and affects the reprogramming of colon cancer cells","volume":"329","author":"Wu","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ncrna.2022.12.006_bib39","doi-asserted-by":"crossref","first-page":"6223","DOI":"10.1007\/s13277-015-3307-4","article-title":"Antagomir-1290 suppresses CD133+ cells in non-small cell lung cancer by targeting fyn-related Src family tyrosine kinase","volume":"36","author":"Sun","year":"2015","journal-title":"Tumor Biol."},{"key":"10.1016\/j.ncrna.2022.12.006_bib40","article-title":"miR-1290 contributes to oncogenesis and angiogenesis via targeting of THBS1, DKK3 and, SCAI","volume":"11","author":"Soheilifar","year":"2021","journal-title":"Bioimpacts"},{"key":"10.1016\/j.ncrna.2022.12.006_bib41","first-page":"1570","article-title":"miR-1290 is a potential prognostic biomarker in non-small cell lung cancer","volume":"7","author":"Mo","year":"2015","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.ncrna.2022.12.006_bib42","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/humupd\/dms048","article-title":"Genetic and epigenetic instability in human pluripotent stem cells","volume":"19","author":"Nguyen","year":"2013","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.ncrna.2022.12.006_bib43","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nbt.1516","article-title":"Characterization of human embryonic stem cells with features of neoplastic progression","volume":"27","author":"Werbowetski-Ogilvie","year":"2009","journal-title":"Nat. Biotechnol."}],"container-title":["Non-coding RNA Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246805402200083X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246805402200083X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T04:29:14Z","timestamp":1762835354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246805402200083X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S246805402200083X"],"URL":"https:\/\/doi.org\/10.1016\/j.ncrna.2022.12.006","relation":{},"ISSN":["2468-0540"],"issn-type":[{"value":"2468-0540","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating liver cancer stem cells and their stemness-associated MicroRNAs as diagnostic and prognostic biomarkers for viral hepatitis-induced liver cirrhosis and hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Non-coding RNA Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncrna.2022.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by KeAi Communications Co., Ltd.","name":"copyright","label":"Copyright"}]}}